 Home > Biochemistry News > Biotechnology News > Reindeer Bio's CAR-T Products Accepted Clinical Application for New Autoimmune Disease Indications

Reindeer Bio's CAR-T Products Accepted Clinical Application for New Autoimmune Disease Indications

 Last Update: 2022-08-10
 Source: Internet
 Author: User

Tags

amikacin injection

tylenol slow release

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 28, the CDE official website announced that Reindeer Bio submitted two clinical trial applications for Iquilenx injection, which were accept.

Screenshot source: CDE official website

This is the first clinical trial application submitted in China for CAR-T cell therapy for the treatment of autoimmune diseases, and the world's first clinical trial application for CAR-T treatment of neuromyelitis optica spectrum diseas.

According to public information, CT103A is an innovative BCMA-targeting CAR-T product candidate jointly developed by Reindeer Bio and Innovent B.

This time, the clinical trial application submitted by CT103A is for a new indication, neuromyelitis optica spectrum disorder (NMOS.

This new indication application is based on a clinical study (Investigator Initiated Trial, IIT) initiated by the investigator of Iquilenza Injecti.

The research data preliminarily show that the 5×106 CAR-T cells/kg and 0×106 CAR-T cells/kg dose groups of Iquilenxe injection have shown a more reliable performance in the treatment of NMOSD subjects that are poorly controlled by traditional thera.

Reference source: Pharmaceutical Guanlan, PR Newswire

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.